BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19956838)

  • 1. Use of protein array to investigate receptor tyrosine kinases activated in gastric cancer.
    Gong J; Morishita A; Kurokohchi K; Tani J; Kato K; Miyoshi H; Inoue H; Kobayashi M; Liu S; Murota M; Muramatsu A; Izuishi K; Suzuki Y; Yoshida H; Uchida N; Deguchi K; Iwama H; Ishimaru I; Masaki T
    Int J Oncol; 2010 Jan; 36(1):101-6. PubMed ID: 19956838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
    Etoh T; Inoue H; Tanaka S; Barnard GF; Kitano S; Mori M
    Cancer Res; 2001 Mar; 61(5):2145-53. PubMed ID: 11280779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of protein array to identify targetable receptor tyrosine kinases for treatment of human colon cancer.
    Morishita A; Gong J; Nomura T; Yoshida H; Izuishi K; Suzuki Y; Kushida Y; Haba R; D'Armiento J; Masaki T
    Int J Oncol; 2010 Oct; 37(4):829-35. PubMed ID: 20811704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.
    Tari AM; Hung MC; Li K; Lopez-Berestein G
    Oncogene; 1999 Feb; 18(6):1325-32. PubMed ID: 10022814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis.
    Chakroborty D; Sarkar C; Mitra RB; Banerjee S; Dasgupta PS; Basu S
    Clin Cancer Res; 2004 Jul; 10(13):4349-56. PubMed ID: 15240521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
    Wang CH; Tang CW
    Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer.
    Müller-Tidow C; Diederichs S; Bulk E; Pohle T; Steffen B; Schwäble J; Plewka S; Thomas M; Metzger R; Schneider PM; Brandts CH; Berdel WE; Serve H
    Cancer Res; 2005 Mar; 65(5):1778-82. PubMed ID: 15753374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.
    Kuroda T; Kitadai Y; Tanaka S; Yang X; Mukaida N; Yoshihara M; Chayama K
    Clin Cancer Res; 2005 Nov; 11(21):7629-36. PubMed ID: 16278381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma.
    Kiyono K; Suzuki HI; Morishita Y; Komuro A; Iwata C; Yashiro M; Hirakawa K; Kano MR; Miyazono K
    Cancer Sci; 2009 Oct; 100(10):1809-16. PubMed ID: 19594546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma.
    Liu S; Gong J; Morishita A; Nomura T; Miyoshi H; Tani J; Kato K; Yoneyama H; Deguchi A; Mori H; Mimura S; Nomura K; Himoto T; Deguchi K; Okano K; Izuishi K; Suzuki Y; Kushida Y; Haba R; Iwama H; Masaki T
    Exp Ther Med; 2011 May; 2(3):399-403. PubMed ID: 22977516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1.
    Fu YG; Sung JJ; Wu KC; Bai AH; Chan MC; Yu J; Fan DM; Leung WK
    Cancer Lett; 2006 Nov; 243(2):246-54. PubMed ID: 16412567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
    Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
    Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
    Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
    Emanuel SL; Hughes TV; Adams M; Rugg CA; Fuentes-Pesquera A; Connolly PJ; Pandey N; Moreno-Mazza S; Butler J; Borowski V; Middleton SA; Gruninger RH; Story JR; Napier C; Hollister B; Greenberger LM
    Mol Pharmacol; 2008 Feb; 73(2):338-48. PubMed ID: 17975007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
    Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
    Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.